Back to Search
Start Over
LBA88 Belzutifan versus everolimus in participants (pts) with previously treated advanced clear cell renal cell carcinoma (ccRCC): Randomized open-label phase III LITESPARK-005 study.
- Source :
-
Annals of Oncology . 2023 Supplement 2, Vol. 34, pS1329-S1330. 2p. - Publication Year :
- 2023
- Subjects :
- *RENAL cell carcinoma
*EVEROLIMUS
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 34
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 173099662
- Full Text :
- https://doi.org/10.1016/j.annonc.2023.10.090